Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Tirzepatide receptor pharmacology and predicted receptor occupancy GIPR-forward dual-incretin design, cAMP-biased GLP-1R with low beta-arrestin, GCGR negative control (EC50 329 nM)
It also probably includes a contribution from antibody-mediated neutralization
These can be exact replicas (bioidentical) or altered to enhance stability, potency, or half-life
Repurposing metformin to treat age-related neurodegenerative disorders and ischemic stroke
Destruction and reformation of an iron-sulfur cluster during catalysis by lipoyl synthase
MED12 alterations in both human benign and malignant uterine soft tissue tumors
US$ 24.85
US$ 28.85
US$ 26.25
